The impact of angiotensin-receptor neprilysin inhibitors on cardiovascular events and solute transport function in peritoneal dialysis patients: a multicenter retrospective controlled study.

In the subgroup study, we demonstrated that compared with RASi, the use of ARNI showed a trend toward reducing the incidence of cardiovascular events, with a statistically significant difference between the two groups (HR 2.811, 95%CI 1.063 − 7.434, p = 0.033), which was consistent with previous research findings.

also in 24,539 other papers